This has been consolidating since early January, and a good earnings report came out last week. Squeeze momentum indicator is screaming at me to buy, but I'll hold off until (if and when) it hits the $8.74 area of interest.
Mimedx Group Inc ( NASDAQ:MDXG ) Analysis
Sector: Healthcare - Biotechnology | Country: USA
Company Overview:
Mimedx Group Inc, operating in the dynamic biotechnology sector, holds a prominent position in the healthcare industry. With a focus on innovation and biotechnological advancements, the company plays a crucial role in shaping the future of...
Price broke out in 2017 and is currently testing its high levels after the rally up!
The stock is very volatile and It seems there is some weakness in the momentum it once carried.
I'm going ahead to short this; let's see if the volatility plays out in my favor towards the downside.
Sorry, I'm just a contrarian.
Stop at 17.37
Target at 15.72
MDXG
Correction could be over and we should wait the breakout of the structure to the upside.
Bullish divergence supports the idea.
Previous top could be the minimum target at 17.47.
MDXG formed a rounded bottom. looks good on all indicators, it is with the trend and has a good pattern formation. I like this one a lot.
Weekly
looks good. MACD and OBV look good. Stock is forming an nice U shaped breakout
Monthly
MACD looks good, OBV not so much, but the stock continues to make a series of higher highs and higher lows.
Being below its below its 5, 20 & 50 day exponential moving averages and located in the middle of the declining channel the share price of MDXG is considered strongly bearish, though we would expect slight buying pressure. It might be attributed to a valid support level which the stock used to touch several times in 2015 and 2016 but failed to...
Investors are expecting big things in MiMedx which is why growth is not cheap. The forward P/E is 33.6, the PEG is 6.35, and the P/S is 7.26. Still, revenue growth over the last 4 years has been shocking.
In 2011, revenue was $7.8 million. In 2014, revenue had grown to $118.2 million. That’s more than a +1,500% increase in revenue over the last 4 years.
The...
this pattern repeats itself in strong stocks. but it is a tough one to catch. 2 resistances lines turned to support, coinciding with the 40wk moving average. i need to keep a 'pullback' list and watch out for these regularly. great risk reward setup if you can catch them.
